AIRTO member CPI has marked 10 years since the opening of their National Biologics Manufacturing Centre in Darlington, celebrating a decade that has helped shape the UK’s biologics and RNA manufacturing landscape.
The centre, officially named the Nigel Perry Building in 2024 to honour CPI’s founding CEO, has supported hundreds of companies to bring breakthrough medicines to market and created high-value jobs in the North East of England.
Since opening in 2015 with £38 million of government investment, the Darlington centre has collaborated with more than 220 organisations to deliver over 250 R&D projects valued at over £97 million. Each year, the team helps to develop around 40 new products or processes for partners ranging from start-ups to global pharmaceutical companies.
